NCT02389088View on ClinicalTrials.gov

Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH.

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Letrozole

In Phase II, letrozole, 5 mg/day, will be given for 14 days

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02389088 - Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH. | Biotech Hunter | Biotech Hunter